#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Precursor T-lymphoblastic lymphoma/leukaemia recurrent Granulomatosis with polyangiitis Thyroid cancer metastatic Philadelphia chromosome positive Palmoplantar pustulosis Metastases to peritoneum Brain abscess Ocular lymphoma Kidney transplant rejection Ocular myasthenia Optic glioma Fibrodysplasia ossificans progressiva Immunoglobulin G4 related disease Laryngeal squamous cell carcinoma Red blood cell abnormality More trials…

    Learn about Rare Diseases

    Angiosarcoma metastatic – Life with Disease Wolfram syndrome Primary hyperoxaluria X-linked lymphoproliferative syndrome – Diagnostics Skin angiosarcoma – Basic Information Chondrosarcoma metastatic Inclusion body myositis – Life with Disease Atypical teratoid/rhabdoid tumour of CNS – Treatment Synovial sarcoma – Diagnostics Andersen-Tawil syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    KETOROLAC TROMETAMOL Vsf1.01 Colesevelam Alemtuzumab Methoxsalen Hydrocortisone Ph. Eur. Botulinum Toxin Type A Xanthum Gum Vidutolimod Fosfomycin BENZYLPENICILLIN PROCAINE Cart45Ra-Nkg2D Cells Bidridistrogene Xeboparvovec CHLORMADINONE ACETATE Gd2Il18Cart Aluminium Gsk4004280 Dantrolene Sodium Candesartan Hmb-001 More therapies…

    Learn about Your Condition

    Bronchiolitis Phenylketonuria Laryngeal cancer stage I Noninfective chorioretinitis Sarcoma metastatic Herpes simplex meningitis Bone marrow failure Intestinal infarction Oesophagogastroscopy Cervix carcinoma stage II Metachromatic leukodystrophy Lymphocytic lymphoma Pulmonary vascular disorder Muscle injury Pancreatic neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Study on Reducing Acute Kidney Injury After Heart Surgery Using Angiotensin II or Noradrenaline for Patients with Low Blood Pressure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • ANGIOTENSIN II
    • Noradrenaline Tartrate
    Germany

  • Study on Clindamycin and Rifampicin for Treating Infections in Patients with Obesity, Fracture-Related Infections, Hidradenitis Suppurativa, or Prosthetic Joint Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Fracture infection
    • Medical device site joint infection
    Investigated Drugs:
    • Clindamycin Hydrochloride
    • Rifampicin
    Belgium

  • Study on the Effects of Cholecalciferol and Glycerol on Inflammation in Obese Elderly Patients with Vitamin D Deficiency

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Glycerol
    • Colecalciferol
    Italy

  • Study on the Safety of Rotigotine for Patients with Autosomal Dominant Polycystic Kidney Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Rotigotine
    France

  • Study on Bevacizumab and Dexamethasone for Treating Brain Radiation Damage in Patients with High-Grade Glioma or Brain Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Bevacizumab
    The Netherlands

  • Comparison of Two Vitamin D3 Doses (500,000 IU vs 750,000 IU) in Critically Ill Patients with Vitamin D Deficiency Receiving Continuous Renal Replacement Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Colecalciferol
    Poland
Previous Page
1 … 3 4 5 6 7 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!